Exact Mass: 472.2226
Exact Mass Matches: 472.2226
Found 197 metabolites which its exact mass value is equals to given mass value 472.2226
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-Hydroxy-imipramine glucuronide
2-Hydroxy-imipramine glucuronide is a metabolite of imipramine. Imipramine (sold as Antideprin, Deprimin, Deprinol, Depsol, Depsonil, Dynaprin, Eupramin, Imipramil, Irmin, Janimine, Melipramin, Surplix, Tofranil), also known as melipramine, is an antidepressant medication, a tricyclic antidepressant of the dibenzazepine group. Imipramine is mainly used in the treatment of major depression and enuresis (inability to control urination). It has also been evaluated for use in panic disorder. (Wikipedia)
Lexaptepid pegol
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent C274 - Antineoplastic Agent > C129821 - Antineoplastic Biological Agent C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C307 - Biological Agent
Euchrenone a15
2-{[(5S)-5,6,7,8-tetrahydro-9-hydroxy-3,5-dimethylnaphthol[2,3-b]furan-4-yl]methyl}-3,5-dimethyl-6-[(3E)-pent-3-en-1-yl]-1-benzofuran-4,7-dione
5-hydroxy-8-methyl-6-(2-methylbutanoyl)-8-(4-methylpent-3-enyl)-4-phenyl-2h-pyrano[2,3-h]chromen-2-one
5-formyloxy-3,4-dimethoxy-benzoic acid 11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Formylcinegallein
Asp Glu Ile Pro
Asp Glu Leu Pro
Asp Glu Pro Ile
Asp Glu Pro Leu
Asp Ile Glu Pro
Asp Ile Pro Glu
Asp Lys Asn Pro
Asp Lys Pro Asn
Asp Leu Glu Pro
Asp Leu Pro Glu
Asp Asn Lys Pro
Asp Asn Pro Lys
Asp Pro Glu Ile
Asp Pro Glu Leu
Asp Pro Ile Glu
Asp Pro Lys Asn
Asp Pro Leu Glu
Asp Pro Asn Lys
Glu Asp Ile Pro
Glu Asp Leu Pro
Glu Asp Pro Ile
Glu Asp Pro Leu
Glu Glu Pro Val
Glu Glu Val Pro
Glu Ile Asp Pro
Glu Ile Pro Asp
Glu Leu Asp Pro
Glu Leu Pro Asp
Glu Pro Asp Ile
Glu Pro Asp Leu
Glu Pro Glu Val
Glu Pro Ile Asp
Glu Pro Leu Asp
Glu Pro Val Glu
Glu Val Glu Pro
Glu Val Pro Glu
Ile Asp Glu Pro
Ile Asp Pro Glu
Ile Glu Asp Pro
Ile Glu Pro Asp
Ile Pro Asp Glu
Ile Pro Glu Asp
Lys Asp Asn Pro
Lys Asp Pro Asn
Lys Asn Asp Pro
Lys Asn Pro Asp
Lys Pro Asp Asn
Lys Pro Asn Asp
Leu Asp Glu Pro
Leu Asp Pro Glu
Leu Glu Asp Pro
Leu Glu Pro Asp
Leu Pro Asp Glu
Leu Pro Glu Asp
Asn Asp Lys Pro
Asn Asp Pro Lys
Asn Lys Asp Pro
Asn Lys Pro Asp
Asn Pro Asp Lys
Asn Pro Lys Asp
Pro Asp Glu Ile
Pro Asp Glu Leu
Pro Asp Ile Glu
Pro Asp Lys Asn
Pro Asp Leu Glu
Pro Asp Asn Lys
Pro Glu Asp Ile
Pro Glu Asp Leu
Pro Glu Glu Val
Pro Glu Ile Asp
Pro Glu Leu Asp
Pro Glu Val Glu
Pro Ile Asp Glu
Pro Ile Glu Asp
Pro Lys Asp Asn
Pro Lys Asn Asp
Pro Leu Asp Glu
Pro Leu Glu Asp
Pro Asn Asp Lys
Pro Asn Lys Asp
Pro Pro Pro Tyr
Pro Pro Tyr Pro
Pro Gln Gln Thr
Pro Gln Thr Gln
Pro Thr Gln Gln
Pro Val Glu Glu
Pro Tyr Pro Pro
Gln Pro Gln Thr
Gln Pro Thr Gln
Gln Gln Pro Thr
Gln Gln Thr Pro
Gln Thr Pro Gln
Gln Thr Gln Pro
Thr Pro Gln Gln
Thr Gln Pro Gln
Thr Gln Gln Pro
Val Glu Glu Pro
Val Glu Pro Glu
Val Pro Glu Glu
Tyr Pro Pro Pro
B5R5IQ1D64
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[1-[[(2R,3R,4S,5S)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]amino]-3-(4-methoxyphenyl)-1-oxopropan-2-yl]azanium
4-{[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanyl}benzoic acid
Puromycin(1+)
Puromycin monoprotonated at the amino nitrogen. It is the predominant species at pH 7.3.
1-(3-Methylphenyl)-3-[[1-[4-(4-morpholinylsulfonyl)phenyl]-4-piperidinyl]methyl]urea
1-(2-Methylphenyl)-3-[[1-[4-(4-morpholinylsulfonyl)phenyl]-4-piperidinyl]methyl]urea
2-[(3S,6aR,8R,10aR)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
2-[(3R,6aR,8S,10aR)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
2-[(3S,6aR,8S,10aR)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
2-[(3R,6aS,8R,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
2-[(3S,6aS,8R,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(3R,6aR,8R,10aR)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
2-[(3S,6aS,8S,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(3R,6aS,8S,10aS)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide
[(1R)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(1S)-2-[(4-fluorophenyl)methyl]-7-methoxy-1-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(1-acetyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
PF-00835231
A primary alcohol resulting from the cleavage of the phosphate group of the prodrug PF-07304814. It is an inhibitor of SARS-CoV-1 and -2 main protease (3CLpro) and exhibits potent in vitro antiviral activity.